1 Glenmark's Clindamycin Phosphate Foam, 1% is only approved for the indication(s) listed in Glenmark's approved label. 2 All brand names and trademarks are the property of their respective owners.

Glenmark Pharmaceuticals Inc., USA (Glenmark) announced the launch of Clindamycin Phosphate Foam, 1%. Glenmark's Clindamycin Phosphate Foam, 1% is bioequivalent and therapeutically equivalent to the ...

Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch1 of Clindamycin Phosphate Foam, 1%. Glenmark's Clindamycin Phosphate Foam, 1% is bioequivalent and therapeutically equivalent to ...

Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch of clindamycin phosphate foam, 1%. Glenmark’s clindamycin phosphate foam, 1% is bioequivalent and therapeutically equivalent to the ...

(RTTNews) - India-based Glenmark Pharmaceuticals Inc.'s USA subsidiary, Thursday announced the launch of Clindamycin Phosphate Foam, 1 percent for the treatment of acne. The company added that ...

1 Glenmark’s Clindamycin Phosphate Foam, 1% is only approved for the indication(s) listed in Glenmark’s approved label. 2 All brand names and trademarks are the property of their respective owners. 3 ...

Glenmark Pharmaceuticals on Wednesday, February 12, said its US-based subsidiary launched Clindamycin Phosphate Foam, which is used for the treatment of acne. This new product is bioequivalent and ...

Investing.com -- Glenmark Pharmaceuticals (NSE:GLEN) Inc., USA, has announced the launch of Clindamycin Phosphate Foam, 1%, a product that is bioequivalent and therapeutically equivalent to Evoclin® ...